BELLINVIA, ANGELO
 Distribuzione geografica
Continente #
NA - Nord America 459
EU - Europa 258
AS - Asia 168
AF - Africa 1
Totale 886
Nazione #
US - Stati Uniti d'America 453
IT - Italia 79
HK - Hong Kong 62
IE - Irlanda 59
SE - Svezia 37
JO - Giordania 26
CN - Cina 22
SG - Singapore 22
RU - Federazione Russa 21
PL - Polonia 20
KR - Corea 18
GB - Regno Unito 10
MK - Macedonia 10
PH - Filippine 9
CA - Canada 6
UA - Ucraina 5
BG - Bulgaria 4
IN - India 4
CH - Svizzera 3
DE - Germania 3
CZ - Repubblica Ceca 2
FR - Francia 2
IR - Iran 2
RO - Romania 2
VN - Vietnam 2
IL - Israele 1
RS - Serbia 1
UG - Uganda 1
Totale 886
Città #
Chandler 61
Dublin 59
Hong Kong 46
Fairfield 43
Ashburn 30
Lawrence 30
Altamura 28
Woodbridge 26
Seattle 22
Houston 21
Warsaw 20
Moscow 19
Seoul 18
Wilmington 18
Cambridge 17
Buffalo 16
Princeton 16
Beijing 12
Ann Arbor 11
Boston 10
Florence 9
Singapore 9
Medford 8
San Diego 8
Shanghai 7
New York 6
Caserta 5
Olongapo City 4
Saronno 4
Skopje 4
Toronto 4
Cagayan de Oro 3
Chennai 3
London 3
Andover 2
Basel 2
Boardman 2
Brno 2
Falls Church 2
Fuzhou 2
Kent 2
Laurel 2
Milan 2
Montreal 2
New Bedfont 2
Redwood City 2
Ugong Norte 2
West Jordan 2
Acton 1
Bagno a Ripoli 1
Bari 1
Belfast 1
Belgrade 1
Bern 1
Bologna 1
Bremen 1
Changsha 1
Chicago 1
Figline Valdarno 1
Hillsboro 1
Jerusalem 1
Lanciano 1
Lviv 1
Marano di Napoli 1
Munich 1
Norwalk 1
Nuremberg 1
Ohrid 1
Palermo 1
Portland 1
Prescot 1
Redmond 1
Rome 1
Saint Petersburg 1
Tappahannock 1
Washington 1
Totale 656
Nome #
Identifying risk factors for cognitive issues in Multiple Sclerosis 118
Cognitive impairment in multiple sclerosis: An exploratory analysis of environmental and lifestyle risk factors 107
The clinical spectrum of anti-MOG associated acquired demyelinating disorders: Three case-reports 77
Prognostic role of intrathecal IgM synthesis in multiple sclerosis: Results from a clinical series 75
Disease-modifying drugs can reduce disability progression in relapsing multiple sclerosis 59
Experience with rituximab therapy in a real-life sample of multiple sclerosis patients 53
Cognitive reserve is a determinant of social and occupational attainment in patients with pediatric and adult onset multiple sclerosis 48
A new paraplegin mutation in a patient with primary progressive multiple sclerosis 47
Cerebrospinal fluid igm and oligoclonal igg bands in multiple sclerosis: A meta-analysis of prevalence and prognosis 42
Progression is independent of relapse activity in early multiple sclerosis: a real-life cohort study 42
Effect of BDNF Val66Met polymorphism on hippocampal subfields in multiple sclerosis patients 41
The Brain-Derived Neurotrophic Factor Val66Met Polymorphism Can Protect Against Cognitive Impairment in Multiple Sclerosis 39
Pregnancy in multiple sclerosis women with relapses in the year before conception increases the risk of long-term disability worsening 37
Long-term Cognitive Outcomes and Socioprofessional Attainment in People With Multiple Sclerosis With Childhood Onset 34
Safety and efficacy of eculizumab therapy in multiple sclerosis: A case series 26
The risk of infections for multiple sclerosis and neuromyelitis optica spectrum disorder disease-modifying treatments: Eighth European Committee for Treatment and Research in Multiple Sclerosis Focused Workshop Review. April 2021 25
Disease-Modifying Treatments and Time to Loss of Ambulatory Function in Patients with Primary Progressive Multiple Sclerosis 18
Current advances in the pharmacological prevention and management of cognitive dysfunction in multiple sclerosis 17
Hypogammaglobulinemia is associated with reduced antibody response after anti-SARS-CoV-2 vaccination in MS patients treated with antiCD20 therapies 9
Totale 914
Categoria #
all - tutte 4.650
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.650


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020120 0 7 0 6 12 13 17 12 17 9 20 7
2020/2021111 11 7 10 15 2 9 4 8 11 24 3 7
2021/2022130 3 3 7 3 2 14 2 6 16 11 28 35
2022/2023337 26 79 27 9 10 50 36 26 51 4 16 3
2023/2024197 2 13 25 14 11 10 8 53 10 16 25 10
2024/202516 16 0 0 0 0 0 0 0 0 0 0 0
Totale 914